MaxQ & TBARead more
MaxQ & TBARead more
Max Q & TBARead more
Presenting this month: Life Equals & Progentec – Please NOTE the change in regular meeting time. LifeEquals Red Bull proved the model. 5-Hour Energy did it again. Life Equals is the “3rd time charm”. Life Equals is a progressive wellness brand and inventor of Balance, the Superfood Shot® – the first Superfood Shot® on the marketRead more
Presenting this month: Life Equals & Progentec LifeEquals Red Bull proved the model. 5-Hour Energy did it again. Life Equals is the “3rd time charm”. Life Equals is a progressive wellness brand and inventor of Balance, the Superfood Shot® – the first Superfood Shot® on the market that provides ½ your daily requirements of fruitsRead more
Presenting this month: Tetherex & SendaRide Tetherex is focused on development of an anti-PSGL-1 antibodies for the treatment of inflammatory and thrombotic diseases. The lead indication is a treatment for Crohn’s Disease (CD). In mild to moderate disease Tetherex may improve the symptoms of CD when used in conjunction with medications such as antibiotics, andRead more
Presenting this month: Tetherex & SendaRide Tetherex is focused on development of an anti-PSGL-1 antibodies for the treatment of inflammatory and thrombotic diseases. The lead indication is a treatment for Crohn’s Disease (CD). In mild to moderate disease Tetherex may improve the symptoms of CD when used in conjunction with medications such as antibiotics, andRead more
Presenting this month: Moleculera & Stackify Moleculera Update: Moleculera Labs is a Precision Medicine Diagnostics Company focused on neuropsychiatric disorders in children and adults. Moleculera’s COLA/CLIA accredited clinical laboratory performs tests that direct treatment for neuropsychiatric disorders caused by an immune system dysfunction. Moleculera is an existing i2E portfolio company. CEO, Dr. Craig Shimasaki will be providing a companyRead more
Presenting this month: Moleculera & Stackify Moleculera Update: Moleculera Labs is a Precision Medicine Diagnostics Company focused on neuropsychiatric disorders in children and adults. Moleculera’s COLA/CLIA accredited clinical laboratory performs tests that direct treatment for neuropsychiatric disorders caused by an immune system dysfunction. Moleculera is an existing i2E portfolio company. CEO, Dr. Craig Shimasaki will be providing a companyRead more